Anheart Therapeutics Raises $61 Million In Oversubscribed Series B Financing To Advance Precision Oncology Pipeline
Amount Raised
$61 Million
Round Type
Series B
New YorkManufacturingBiotechnologyHealth CareScience And EngineeringTherapeuticsPharmaceuticalBiopharmaDescription
AnHeart Therapeutics (“AnHeart”), a clinical-stage global biopharmaceutical group company committed to developing novel precision oncology therapies, today announced the completion of a $61 million oversubscribed Series B financing round led by new investor Octagon Capital, with participation from Innovent Biologics, Cenova, Laurion Capital, and Sage Partners. The Company has raised a total of $100 million in gross proceeds from private financings since its founding in December 2018.
Quick answer
AnHeart Therapeutics raised $61 Million in a Series B round, dated December 14, 2021. AnHeart Therapeutics is based in New York, New York, United States.
- How much did AnHeart Therapeutics raise?
- AnHeart Therapeutics raised $61 Million in a Series B round on December 14, 2021.
- What does AnHeart Therapeutics do?
- AnHeart Therapeutics Ltd. is a global clinical-stage biopharmaceutical company developing novel precision therapies for people with cancer.
- Where is AnHeart Therapeutics based and how big is it?
- AnHeart Therapeutics is based in New York, New York, United States.
- Who are the decision-makers at AnHeart Therapeutics?
- Fundz holds 1 contact at AnHeart Therapeutics. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Science And Engineering and Therapeutics around the same time
Companies in the same sectors as AnHeart Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Arbutus raised $15M on December 30, 2021.
- Amarna Therapeutics raised $5.4M (Funding Round) on December 1, 2021.
- Advanced NanoTherapies raised $9.2M on January 26, 2022.
- Talphera, Inc. raised $5.2M on January 24, 2022.
- Enliven Therapeutics raised an undisclosed amount (Funding Round) on January 19, 2022.
- Co-Diagnostics, Inc. raised $47M on January 14, 2022.
Who to call at AnHeart Therapeutics, and when
A new round usually means AnHeart Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day AnHeart Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at AnHeart Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at AnHeart Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment AnHeart Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansAnHeart Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.